Literature DB >> 22898630

Serum nutritional markers for prediction of pancreatic exocrine insufficiency in chronic pancreatitis.

Björn Lindkvist1, J Enrique Domínguez-Muñoz, María Luaces-Regueira, Margarita Castiñeiras-Alvariño, Laura Nieto-Garcia, Julio Iglesias-Garcia.   

Abstract

BACKGROUND: Methods for evaluation of pancreatic exocrine insufficiency (PEI) are expensive, labor intensive, and not available at many institutions. The aim of this study was to investigate if PEI in chronic pancreatitis (CP) can by predicted by nutritional markers in blood.
METHODS: A retrospective analysis of a prospectively collected database of CP patients was performed. Diagnosis of CP was based on endoscopic ultrasonography or magnetic resonance imaging. PEI was investigated by the (13)C-mixed triglyceride breath test. Hemoglobin, mean corpuscular volume, lymphocytes, prothrombin time, and serum levels of total protein, albumin, prealbumin, retinol binding protein, cholesterol, triglycerides, amylase, folic acid, vitamin B12, HbA1C, transferrin, ferritin, magnesium and zinc were analyzed.
RESULTS: 114 patients were included in the study (97 males, mean age 48.1 years, 54 with alcohol etiology), 38 (33%) suffered from PEI. Magnesium below 2.05 mg/dL, hemoglobin, albumin, prealbumin and retinol binding protein below lower limit of normal and HbA1C above upper limit of normal were associated with PEI in univariate analysis. Magnesium below 2.05 mg/dL detected PEI with a sensitivity, specificity and positive and negative predictive values of 0.88 (95% confidence interval, 0.66-0.97), 0.66 (0.48-0.80), 0.58 (0.39-0.75) and 0.91 (0.73-0.98), respectively. The corresponding values were 1.00 (0.80-1.00), 0.55 (0.38-0.71), 0.52 (0.34-0.69) and 1.00 (0.82-1.00)) if one or more pathological tests among parameters significantly associated with PEI in was used as a positive test for PEI.
CONCLUSION: Serum nutritional markers can be used to predict the probability of PEI in CP and provide guidance in decisions on enzyme replacement therapy.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22898630     DOI: 10.1016/j.pan.2012.04.006

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  34 in total

1.  Pancrelipase with branched-chain amino acids for preventing nonalcoholic fatty liver disease after pancreaticoduodenectomy.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama; Tokio Higaki; Masamichi Moriguchi; Nao Yoshida; Teruyuki Miyazaki; Yoichi Teshima
Journal:  J Gastroenterol       Date:  2015-04-23       Impact factor: 7.527

Review 2.  Practical guide to the management of chronic pancreatitis.

Authors:  Mustafa Jalal; Jennifer A Campbell; Andrew D Hopper
Journal:  Frontline Gastroenterol       Date:  2018-09-07

3.  Prevalence and Risk Factors for Osteopathy in Chronic Pancreatitis.

Authors:  Xin-Ying Tang; Nan Ru; Qing Li; Yang-Yang Qian; Hui Sun; Jia-Hui Zhu; Lin He; Yuan-Chen Wang; Liang-Hao Hu; Zhao-Shen Li; Wen-Bin Zou; Zhuan Liao
Journal:  Dig Dis Sci       Date:  2021-01-12       Impact factor: 3.199

4.  Pancreatic exocrine insufficiency, diabetes mellitus and serum nutritional markers after acute pancreatitis.

Authors:  Miroslav Vujasinovic; Bojan Tepes; Jana Makuc; Sasa Rudolf; Jelka Zaletel; Tjasa Vidmar; Maja Seruga; Bostjan Birsa
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

Review 5.  The nutritional management of type 3c (pancreatogenic) diabetes in chronic pancreatitis.

Authors:  S N Duggan; N Ewald; L Kelleher; O Griffin; J Gibney; K C Conlon
Journal:  Eur J Clin Nutr       Date:  2016-07-13       Impact factor: 4.016

Review 6.  Chronic pancreatitis: A diagnostic dilemma.

Authors:  Sinead N Duggan; Hazel M Ní Chonchubhair; Oladapo Lawal; Donal B O'Connor; Kevin C Conlon
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 7.  Management of pain in chronic pancreatitis with emphasis on exogenous pancreatic enzymes.

Authors:  Paul M Hobbs; William G Johnson; David Y Graham
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-08-06

8.  European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations.

Authors:  J-Matthias Löhr; Ulrich Beuers; Miroslav Vujasinovic; Domenico Alvaro; Jens Brøndum Frøkjær; Frank Buttgereit; Gabriele Capurso; Emma L Culver; Enrique de-Madaria; Emanuel Della-Torre; Sönke Detlefsen; Enrique Dominguez-Muñoz; Piotr Czubkowski; Nils Ewald; Luca Frulloni; Natalya Gubergrits; Deniz Guney Duman; Thilo Hackert; Julio Iglesias-Garcia; Nikolaos Kartalis; Andrea Laghi; Frank Lammert; Fredrik Lindgren; Alexey Okhlobystin; Grzegorz Oracz; Andrea Parniczky; Raffaella Maria Pozzi Mucelli; Vinciane Rebours; Jonas Rosendahl; Nicolas Schleinitz; Alexander Schneider; Eric Fh van Bommel; Caroline Sophie Verbeke; Marie Pierre Vullierme; Heiko Witt
Journal:  United European Gastroenterol J       Date:  2020-06-18       Impact factor: 4.623

9.  Pancreatic Function in Chronic Pancreatitis: A Cohort Study Comparing 3 Methods of Detecting Fat Malabsorption and the Impact of Short-term Pancreatic Enzyme Replacement Therapy.

Authors:  Jefferson N Brownell; Joan I Schall; Virginia A Stallings
Journal:  Pancreas       Date:  2019-09       Impact factor: 3.327

Review 10.  Structure and function of the exocrine pancreas in patients with type 1 diabetes.

Authors:  Laure Alexandre-Heymann; Roberto Mallone; Christian Boitard; Raphaël Scharfmann; Etienne Larger
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.